Salivary IgA and periodontal treatment needs in diabetic patients
AUTOR(ES)
Branco-de-Almeida, Luciana Salles, Alves, Cláudia Maria Coêlho, Lopes, Fernanda Ferreira, Pereira, Adriana de Fátima Vasconcelos, Guerra, Rosane Nassar Meireles, Pereira, Antônio Luiz Amaral
FONTE
Brazilian Oral Research
DATA DE PUBLICAÇÃO
2011-12
RESUMO
Salivary IgA can serve as a first line of defense against pathogens that colonize and invade mucosal surfaces and may be protective against periodontal disease. The aim of this study was to assess salivary immunoglobulin A levels in diabetic and non-diabetic patients with different periodontal treatment needs. The Periodontal Screening & Recording (PSR) system was used to evaluate the periodontal treatment needs of 41 diabetic and 42 non-diabetic patients. Unstimulated whole saliva was collected from each patient immediately before clinical examination and stored at -20 °C until analysis. Salivary immunoglobulin A (s-IgA) levels were determined using an enzyme-linked immunosorbent assay, and values were expressed as optical density. Diabetic and non-diabetic patients were compared using clinical and laboratory data. PSR data indicated that periodontal disease was more frequent and more severe in diabetic patients. A higher prevalence of codes 3 and 4 was observed in diabetics as compared with non-diabetics (odds ratio = 2, P < 0.05). Furthermore, non-diabetic patients had more healthy sextants (code 0) than did diabetic patients. Over half of diabetic patients (∼54%) presented with s-IgA levels that were lower than the normal range (optical density from 0.4 nm to 0.6 nm; P < 0.05). In addition, diabetic patients showed a higher variability in s-IgA levels as compared with non-diabetic patients. In conclusion, diabetic individuals had lower s-IgA levels, more-frequent and more-severe periodontal disease, and a greater need for periodontal treatment as compared with non-diabetic patients.
Documentos Relacionados
- Relation between buccal protozoa and pH and salivary IgA in patients with dental prothesis
- Serum and parotid salivary IgA in chronic bronchitis and asthma
- Salivary IgA and IgE levels in healthy subjects: relation to age and gender
- Circulating complexes containing IgA and fibronectin in patients with primary IgA nephropathy.
- Salivary anti-PGL IgM and IgA titers and serum antibody IgG titers and avidities in leprosy patients and their correlation with time of infection and antigen exposure